ReviewESMO open2017
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer.
Clemence Granier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
196 papers cite itlatest 60 shown
this paperpooled ittrialcites it